CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Up 753.2% in November

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 133,100 shares, an increase of 753.2% from the November 15th total of 15,600 shares. Based on an average daily trading volume, of 107,300 shares, the days-to-cover ratio is currently 1.2 days.

CERo Therapeutics Price Performance

NASDAQ CEROW opened at $0.02 on Friday. The company has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.02. CERo Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.25.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.